Atlas Trials

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

Clinical trial NCT05353647 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05353647
Sponsor
David Williams
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2022-07-12
Primary completion
2027-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.